How many insider declarations has Lim Bryant David filed?

Lim Bryant David has filed 3 public insider declarations with SEC (Form 4).

What is Lim Bryant David's role?

Lim Bryant David's reported role is not specified by the regulator across the filings.

Which companies does Lim Bryant David report trades for?

Lim Bryant David reports trades for 2 companies, including Idera Pharmaceuticals, INC..

What is Lim Bryant David's declared buy vs sell volume?

Across the available history, declared buys total 34k€ and disposals 0.

← Executives ★ Sign in to follow

LB

Lim Bryant David

·SEC (Form 4)

Idera Pharmaceuticals, INC.Prelude Therapeutics Inc

0

Total declarations

0

Companies

€33,897

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-37.0%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the complete record of transactions filed by Lim Bryant David. Officer active across 2 companies, notably Idera Pharmaceuticals, INC.. Cumulatively, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 6 January 2023. The latest transaction was disclosed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Lim Bryant David

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Idera Pharmaceuticals, INC. (US)Prelude Therapeutics Inc (US)

Declarations3 total

▲

Lim Bryant David

CLO, Interim CFO, Corp Sec.Executives19 Dec 2024Prelude Therapeutics Inc

$22,63844SEC ↗

25,000 shares@ US$0.905564.5% of flowCommon StockSEC:0001562180-24-008532:0

Canonical exit: 19 Mar 2025 (T+90)

▲

Lim Bryant David

Chief Legal Officer, Corp Sec.Executives24 May 2023Prelude Therapeutics Inc

$12,93637SEC ↗

2,400 shares@ US$5.3935.5% of flowCommon StockSEC:0001562180-23-004479:0

Canonical exit: 22 Aug 2023 (T+90)

◆

Lim Bryant David

SVP AND GENERAL COUNSELExecutives6 Jan 2023Idera Pharmaceuticals, INC.

0SEC ↗

399,218 shares0Common StockSEC:0001415889-23-000765:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

LB

Lim Bryant David

·SEC (Form 4)

Idera Pharmaceuticals, INC.Prelude Therapeutics Inc

0

Total declarations

0

Companies

€33,897

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-37.0%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the complete record of transactions filed by Lim Bryant David. Officer active across 2 companies, notably Idera Pharmaceuticals, INC.. Cumulatively, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 6 January 2023. The latest transaction was disclosed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.